1. Home
  2. NSYS vs SNTI Comparison

NSYS vs SNTI Comparison

Compare NSYS & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nortech Systems Incorporated

NSYS

Nortech Systems Incorporated

HOLD

Current Price

$12.25

Market Cap

25.6M

Sector

Technology

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$0.87

Market Cap

29.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSYS
SNTI
Founded
1981
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.6M
29.8M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
NSYS
SNTI
Price
$12.25
$0.87
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
15.7K
179.4K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
80.85
77.31
EPS
N/A
N/A
Revenue
$14,371,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.01
N/A
52 Week Low
$6.50
$0.77
52 Week High
$15.39
$3.88

Technical Indicators

Market Signals
Indicator
NSYS
SNTI
Relative Strength Index (RSI) 43.69 41.33
Support Level $8.62 $0.81
Resistance Level $15.11 $0.93
Average True Range (ATR) 0.96 0.08
MACD -0.26 -0.01
Stochastic Oscillator 28.26 4.61

Price Performance

Historical Comparison
NSYS
SNTI

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: